ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1000

A Deep-Learning Based Approach Uncovers Novel Mediators of Micro-RNA Restraint of Type-2 Immunity

Shaan Sekhon1, Robin Kageyama2, Neil Sprenkle3, Hannah Happ2, Eric Wigton2, Heather Pua3 and Mark Ansel2, 1University of California, San Francisco, Berkeley, 2University of California, San Francisco, San Francisco, 3Vanderbilt University, Nashville

Meeting: ACR Convergence 2025

Keywords: Bioinformatics, Genomics and Proteomics, Micro-RNA, T Cell, T-Lymphocyte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0978–1006) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: MicroRNAs, such as miR-24 and miR-27, co-expressed within the Mirc11 and Mirc22 clusters, orchestrate a regulatory network critical to Th2 cell differentiation and cytokine production, notably Interleukin-4 (IL-4), with emerging roles in immune dysregulation in rheumatic diseases. To probe this network, we developed DeepRNA-Reg, a deep learning-based algorithm leveraging recurrent neural networks for high-fidelity comparative analysis of high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) datasets.

Methods: The DeepRNA-Reg algorithm utilizes deep learning to predict differentially enriched sites in paired HITS-CLIP data sets, employing a recurrent neural network to infer differential enrichment status across the transcriptome. CD4+ T cells were isolated from spleen and lymph nodes and cultured under Th2 conditions. C57BL/6 male and female age and sex matched mice between 5 to 12 weeks of age were used for all experiments. To generate “miR-23, 24, 27 KO” T cells lacking expression of all Mirc11 cluster miRNAs (miR- 23a, miR-24-2, and miR-27a) and Mirc22 cluster miRNAs (miR-23b, miR-24-1, and miR-27b), we intercrossed previously generated conditionally mutant Mirc22tm1.1Mtm mice and Mirc11tm1.1Mtm mice and with Cd4-Cre transgenic mice (Tg(CD4-cre)1Cwi; 4196, Taconic) to induce Cre-mediated deletion in T cells. Ago2 HITS- CLIP was performed using an anti-Ago2 monoclonal antibody. Lastly, differential protein expression was evaluated in CD4+ T Cells harvested from mice bearing selective microRNA cluster knock-out.

Results: This analysis of miR-24, 27 targets uncovered a suite of transcriptional regulators that are known to affect IL-4 expression, including Gata3 and Ikzf1 but also Rora, Tcf7, Runx1, Bcl11b, Foxo1, Nfat5, Tsc22d3 and Klf11. In addition, this study uncovered the cell surface costimulatory receptor CD28 as a novel target of miR-24 and miR-27. CD28 is a key regulator of T cell activation, differentiation and cytokine production. Flow cytometric analysis of CD28 protein expression confirmed that miR-23,24,27 KO Th2 cells express a larger quantity of CD28 on their cell surface, consistent with direct targeting by miR-24 and/or miR- 27.

Conclusion: These findings demonstrate that DeepRNA-Reg analysis of comparative Ago2 HITS-CLIP data can both confirm prior knowledge and uncover novel nodes in post-transcriptional regulatory networks. In tested data sets, DeepRNA-Reg uncovered novel mediators in the mechanism of microRNA-mediated restraint of type-2 immunity in T-Helper 2 cells, a pattern of immune response implicated in the pathophysiology.

Supporting image 1Benchmarking predicted miRNA target site capture.

(A) Schematic representation of the DeepRNA-Reg algorithm.

(B-C) Seed binding sequence motif abundance in the Th2 differential AHC analysis (B) and the Th17 differential AHC analysis (C) by both DeepRNA-Reg and dCLIP.

(D) Venn diagram quantifying overlap events between Targetscan 7.2 predicted miRNA target sites of miR-23, 24, and 27 and the sites called to be enriched in WT Th2 cells (relative to miR-23,24,27 KO Th2 cells) by both DeepRNA-Reg and dCLIP.

(E) Venn diagram quantifying overlap events between Targetscan 7.2 predicted miRNA target sites of miR-29 and the sites called to be enriched in WT Th17 cells (relative to miR-29 KO Th2 cells) by both DeepRNA-Reg and dCLIP.

Supporting image 2Interrogating the Il-4 regulatory axis in the T Helper 2 Context.

(A) A gene regulatory network showing the intersection of the IPA knowledge bank of known il-4 regulators and high-confidence DeepRNA-Reg predicted microRNA-24,27 targets. This high-confidence prediction set met the following conditions: a differentially enriched site with a DBE score above the median DBE score for the analysis that contains a canonical motif, with a negative response to the corresponding miRNA mimic between 15% and 85%.

(B) A scatterplot of the degree of gene expression change between the miRNA mimic and control condition for microRNAs 24 and 27 on the horizontal and vertical axes, respectively. This plot represents the set of genes that lie at the intersection of the set of known upstream regulators of interluken-4 within the IPA knowledge-base and the set of high-confidence DeepRNA-Reg predictions of miR-24,27 targets.

(C) A line plot representing the read depth across a section of the Cd28 3’UTR for both the WT and miR-23,24,27 KO condition HITS-CLIP experiments. Highlighted within this plot are two loci enriched in the WT condition relative to the miRNA KO condition, called and scored by DeepRNA-Reg, which overlap canonical seed sequences of miRNAs 24 and 27.

(D) Flow cytometric analysis of CD28 protein expression showing that miR-23,24,27 KO Th2 cells express a larger quantity of CD28 on their cell surface, consistent with direct targeting by miR-24 and/or miR-27

Supporting image 3Secondary structure of Ago2 binding sites.

(A-C) Heatmaps represent a visualization of the A/U richness (A) and icSHAPE reactivity score – both in vivo (B) and in vitro (C) – for various sites of putative Ago2-miRNA binding targets. The datasets of putative Ago2-miRNA binding sites are the DeepRNA-Reg and dCLIP predicted set of miR-23,24,27 targets provided by the WT Th2 vs. miR-23,24,27 KO Th2 differential AHC analysis, and the set of all Ago2 binding sites called by the algorithm Clipper 2.0 within a dataset of HITS-CLIP performed within WT T-Helper 2 Cells. Below the heatmaps are line plots representing the average signal presented within the heatmaps, collapsed across all predicted binding sites of Ago2.

(D-F) Heatmaps showing the free energy change of dimerization of a rolling 10-bp window surrounding the miRNA seed containing site and the miRNA seed containing region (a 10 bp window centered at the site center) for the set of all Ago2 binding sites called by the algorithm Clipper 2.0 within a dataset of HITS-CLIP performed within WT T-Helper 2 Cells (D), and the DeepRNA-Reg (E) and dCLIP (F) predicted set of miR-23,24,27 targets provided by the WT Th2 vs. miR-23,24,27 KO Th2 differential AHC analysis. Plots located below show the average signal across all sites presented in the heatmap.


Disclosures: S. Sekhon: None; R. Kageyama: None; N. Sprenkle: None; H. Happ: None; E. Wigton: None; H. Pua: None; M. Ansel: None.

To cite this abstract in AMA style:

Sekhon S, Kageyama R, Sprenkle N, Happ H, Wigton E, Pua H, Ansel M. A Deep-Learning Based Approach Uncovers Novel Mediators of Micro-RNA Restraint of Type-2 Immunity [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-deep-learning-based-approach-uncovers-novel-mediators-of-micro-rna-restraint-of-type-2-immunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-deep-learning-based-approach-uncovers-novel-mediators-of-micro-rna-restraint-of-type-2-immunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology